Expert Opinion On Therapeutic Patents

雜志介紹

Expert Opinion On Therapeutic Patents雜志介紹

《Expert Opinion On Therapeutic Patents》是一本以English為主的未開放獲取國際優秀期刊，中文名稱治療性專利專家意見，本刊主要出版、報道醫學-CHEMISTRY, MEDICINAL領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為5.4，最新CiteScore 指數為12.1。

本刊近期中國學者發表的論文主要有：

• Novel diarylpyrimidines and diaryltriazines as potent HIV-1 NNRTIs with dramatically improved solubility: a patent evaluation of US20140378443A1.

  Author: Huang B, Kang D, Yang J, Zhan P, Liu X.

• RGD mimetics γ-AApeptides and methods of use (US 20,140,004,039 A1): a patent evaluation.

  Author: Wu H, Jiang J, Xu H, Li Q, Cai J.

• Novel serotonin receptor 2 (5-HT2R) agonists and antagonists: a patent review (2004-2014).

  Author: Yang Y, An S, Liu Y, Guo XX, Gao L, Wei JF, Xu TR.

• Analysis of anti-asthmatic drug patents published in China between 2004 and 2013.

  Author: Xie H, Zhang H, Cao K, He P, Dai H, He S.

英文介紹

Expert Opinion On Therapeutic Patents雜志英文介紹

Expert Opinion on Therapeutic Patents (ISSN 1354-3776 [print], 1744-7674 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on recent pharmaceutical patent claims, providing expert opinion the scope for future development, in the context of the scientific literature.

The Editors welcome:

Reviews covering recent patent claims on compounds or applications with therapeutic potential, including biotherapeutics and small-molecule agents with specific molecular targets; and patenting trends in a particular therapeutic area

Patent Evaluations examining the aims and chemical and biological claims of individual patents

Perspectives on issues relating to intellectual property

The audience consists of scientists, managers and decision-makers in the pharmaceutical industry and others closely involved in R&D

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days.